UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019029
Receipt number R000021692
Scientific Title The utility of 11C-choline PET/CT in prostate patients of PSA failure
Date of disclosure of the study information 2015/10/01
Last modified on 2022/02/13 10:04:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The utility of 11C-choline PET/CT in prostate patients of PSA failure

Acronym

11C-choline PET/CT in PSA failure

Scientific Title

The utility of 11C-choline PET/CT in prostate patients of PSA failure

Scientific Title:Acronym

11C-choline PET/CT in PSA failure

Region

Japan


Condition

Condition

Prostate Cancer

Classification by specialty

Urology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To prospectively compare the diagnostic aacuracy and clinical impact for restaging prostate cancer in patients with PSA failure between conventional imaging modalities (pelvis MRI, chest/abdomen CT, bone scintigraphy).

Basic objectives2

Others

Basic objectives -Others

To find the true usefulness of 11C-choline PET/CT for restaging prostate cancer after treatmen.t

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

To compare diagnostic accuracy (ROC analysis, sensitivity, specificity, and accuracy) for diagnosing lymph node recurrence between 11C-choline PET/CT and chest/abdomen CT.

Key secondary outcomes

To compare diagnostic accuracy (ROC analysis, sensitivity, specificity, and accuracy) for diagnosing local recurrence and distant metastasis and clinical impact between 11C-choline PET/CT and chest/abdomen CT.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

11C-choline PET/CT, pelvic MRI, chest/abdomen CT, bone scintigraphy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

100 years-old >=

Gender

Male

Key inclusion criteria

*The patients that the urology department chief physician judged an examination for 11C-Colin PET/CT to be necessary.
*The patients who show PSA failure after the treatments.
*The patients who underwent or will undergo pelvic MRI, chest/abdomen CT, bone scintigraphy.
*The patients in good condition.
*The patients who can understand study contents, and a written agreement is provided

Key exclusion criteria

*The patients who cannot keep face up position because of sharp pain in succession for around 30 minutes.
*The patients with the extreme claustrophobia.
*The patients whom the ADL which I become independent and can inspect is not kept.
*The patients who a study person in charge is judged to be inappropriate.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Koichiro
Middle name
Last name Yamakado

Organization

Hyogo College of Medicine

Division name

Radiology

Zip code

663-8501

Address

Mukogawa-cho 1-1, Nishinomiya, Hyogo

TEL

0798-45-6362

Email

hirota-s@hyo-med.ac.jp


Public contact

Name of contact person

1st name Kazuhiro
Middle name
Last name Kitajima

Organization

Hyogo College of Medicine

Division name

Nuclear Medicine and PET Center

Zip code

663-8501

Address

Mukogawa-cho 1-1, Nishinomiya, Hyogo

TEL

0798-45-6883

Homepage URL


Email

ka-kitajima@hyo-med.ac.jp


Sponsor or person

Institute

Radiology, Hyogo College of Medicine

Institute

Department

Personal name



Funding Source

Organization

Hyogo-prefecture health Foundation
Shinryoku-kai

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Radiology, Hyogo College of Medicine

Address

1-1 Mukogawa-cho 1-1, Nishinomiya, Hyogo 663-8501

Tel

0798-45-6883

Email

kazu10041976@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

兵庫医科大学病院(兵庫県)


Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 01 Day


Related information

URL releasing protocol

http://www.hyo-med.ac.jp/department/radt/

Publication of results

Unpublished


Result

URL related to results and publications

Acta Med Okayama

Number of participants that the trial has enrolled

20

Results

Twenty Japanese prostate cancer patients underwent 11C-choline and FDG PET/CT. The sensitivity/specificity/accuracy/AUC for choline-PET for diagnosing local lesions were 90.9%/100%/95.0%/1.0, whereas those for FDG-PET were 45.5%/100%/75.0%/0.773. Those for choline-PET for node metastasis were 88.9%/100%/95.0%/0.944, and those for FDG-PET were 44.4%/100%/75.0%/0.722. Those for choline-PET for bone metastasis were 84.6%/100%/90.0%/0.951, and those for FDG-PET were 76.9%/100%/85.0%/0.962.

Results date posted

2022 Year 02 Month 13 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Patients scheduled to receive choline PET/CT

Participant flow

From the Urology staff

Adverse events

None

Outcome measures

Diagnostic performance of detecting local prostate cancer, lymph node metastasis, and bone metastasis

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2015 Year 10 Month 01 Day

Date of IRB

2015 Year 08 Month 31 Day

Anticipated trial start date

2015 Year 10 Month 07 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry

2025 Year 12 Month 31 Day

Date trial data considered complete

2025 Year 12 Month 31 Day

Date analysis concluded

2025 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 09 Month 15 Day

Last modified on

2022 Year 02 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021692


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name